Tevogen Bio Holdings Inc./$TVGN
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Tevogen Bio Holdings Inc.
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.
Ticker
$TVGN
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
18
ISIN
US88165K1016
Website
TVGN Metrics
BasicAdvanced
$235M
-
-$0.20
-0.80
-
Price and volume
Market cap
$235M
Beta
-0.8
52-week high
$1.41
52-week low
$0.89
Average daily volume
1.3M
Financial strength
Current ratio
0.353
Quick ratio
0.245
Long term debt to equity
-38.86
Total debt to equity
-62.458
Interest coverage (TTM)
-651.32%
Management effectiveness
Return on assets (TTM)
-578.29%
Return on equity (TTM)
522.96%
Valuation
Price to book
-14.25
Price to tangible book (TTM)
-14.25
Price to free cash flow (TTM)
-14.871
Growth
Earnings per share change (TTM)
-91.08%
TVGN News
AllArticlesVideos
Tevogen Details its Artificial Intelligence Initiative, Tevogen.AI; Proprietary AI-Powered Immunotherapy with Microsoft and Databricks Partnerships
GlobeNewsWire·5 days ago
Tevogen Bio Plans to Expand Specialty Care Pipeline to Include Patients 65+, Building on Previous Forecast of Nearly $1 Billion in Launch-Year; Updated rNPV to Follow
GlobeNewsWire·2 weeks ago
Tevogen to Update on Robust Portfolio Assets, Business Expansion, Partnerships, Limited Tradable Float, High Insider Ownership and Strong Investor Confidence Ahead of June 23 Annual Meeting
GlobeNewsWire·2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Tevogen Bio Holdings Inc. stock?
Tevogen Bio Holdings Inc. (TVGN) has a market cap of $235M as of June 04, 2025.
What is the P/E ratio for Tevogen Bio Holdings Inc. stock?
The price to earnings (P/E) ratio for Tevogen Bio Holdings Inc. (TVGN) stock is 0 as of June 04, 2025.
Does Tevogen Bio Holdings Inc. stock pay dividends?
No, Tevogen Bio Holdings Inc. (TVGN) stock does not pay dividends to its shareholders as of June 04, 2025.
When is the next Tevogen Bio Holdings Inc. dividend payment date?
Tevogen Bio Holdings Inc. (TVGN) stock does not pay dividends to its shareholders.
What is the beta indicator for Tevogen Bio Holdings Inc.?
Tevogen Bio Holdings Inc. (TVGN) has a beta rating of -0.8. This means that it has an inverse relation to market volatility.